Search
for
Sort by
Research 631–660 of 1000+
- Sexual dysfunction in men taking systemic dermatologic medication: A systematic review
- A cross‐sectional analysis of medications used by patients reporting alopecia areata on the FDA adverse events reporting system
- Variability of Retail Pricing of Generic Urologic Medications in a Major US Metropolitan Area
- Molybdenum Nanoparticles as a Potential Topical Medication for Alopecia Treatment Through Antioxidant Pathways that Differ from Minoxidil
- The adverse effects of commonly used medications on male fertility: a comprehensive review
- Advancements in Drug Repurposing: Examples in Psychiatric Medications
- PSAT097 Patient Preference Research: Preferred Adjunctive Medication Attributes of Adult Patients with Classic Congenital Adrenal Hyperplasia
- 1304 Assessing Post Operative Continuation of LUTs Medication Following TURP and BiPolep
- Effects of local and systemic medications on eye health: Adverse reactions
- 180 Impact of underlying medical conditions and medications on edema development in alopecia patients receiving low-dose oral minoxidil (LDOM)
- Molybdenum Nanoparticles as a Potential Topical Medication for Alopecia Treatment through Antioxidant Pathways that Differ from Minoxidil
- Topical minoxidil for nail growth: A conventional medication with a novel indication
- 0557 Possible Contributory and Protective Factors in Medication Associated Obstructive Sleep Apnea (OSA): Results from the US Food and Drug Administration (FDA) Adverse Events Reporting System (FAERS)
- PD35-08 ASSOCIATION OF COMMON MEDICATION WITH PROSTATE-SPECIFIC ANTIGEN LEVEL IN 45-YEAR-OLD GERMAN MEN: RESULTS OF THE PROBASE TRIAL
- Prescription and Over-the-Counter Medications Tool Kit
- Dermatologic Side Effects of Psychotropic Medications
- Safety concerns when using novel medications to treat alopecia
- Cutaneous Toxicities From Transplantation-Related Medications
- Cosmetic adverse effects of antiseizure medications; A systematic review
- The efficacy and safety of valproic acid medications with controlled active ingredient release in adults in real clinical practice from the position of pharmacokinetic and pharmacogenetic approaches
- Dermatologic Implications of Glycemic Control Medications for Patients with Type 2 Diabetes Mellitus
- A Retrospective Case-Control Study Evaluating Medications Associated with Inpatient Falls in a Single Veterans Affairs Medical Center
- Dermatologic Implications of GLP-1 Receptor Agonist Medications: A Comprehensive Review
- Peer Review #7 of "The mediation role of sleep on the relationship between drinks behavior and female androgenetic alopecia (v0.1)"
- Peer Review #3 of "The mediation role of sleep on the relationship between drinks behavior and female androgenetic alopecia (v0.1)"
- Peer Review #7 of "The mediation role of sleep on the relationship between drinks behavior and female androgenetic alopecia (v0.2)"
- Peer Review #6 of "The mediation role of sleep on the relationship between drinks behavior and female androgenetic alopecia (v0.1)"
- Response to Mounessa et al.’s “Commonly prescribed medications associated with alopecia’’
- "Pin the Macho on the Man": Mediations of Gay Male Masculinity in 'The Body Politic', 1971-1987
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors